Catalyst Wire Dossier Catalyst Wire Dossier

solifenacin/tamsulosin combination therapy

· Jeil Pharmaceutical Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for solifenacin/tamsulosin combination therapy, covering 2019-08-29 to 2019-08-29. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial to Compare the Solifenacin/Tamsulosin Combination Therapy With Tamsulosin Monotherapy for LUTS Due to BPH [Phase 3]

See pricing